Format

Send to

Choose Destination
Nat Med. 2011 Oct 2;17(10):1228-30. doi: 10.1038/nm.2435.

Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors.

Author information

1
Department of Neuroscience, University of Turin Medical School and National Institute of Neuroscience (INN), Turin, Italy. fabrizio.benedetti@unito.it

Abstract

Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far nothing is known about the nonopioid component. Here we show that the specific CB1 cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (rimonabant or SR141716) blocks nonopioid placebo analgesic responses but has no effect on opioid placebo responses. These findings suggest that the endocannabinoid system has a pivotal role in placebo analgesia in some circumstances when the opioid system is not involved.

PMID:
21963514
DOI:
10.1038/nm.2435
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for University of Turin Instituional Repository AperTO
Loading ...
Support Center